Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 13/20 | 0.42 |
| ▸ | BCL2 | P10415 | 1/20 | 0.37 |
| ▸ | BECN1 | Q14457 | 1/20 | 0.37 |
| ▸ | KDM4D | Q6B0I6 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3738734 | 0.87 | BCL2 (0.38) | BCL2BECN1KDM4D | |
| SCHEMBL3746198 | 0.83 | BCL2 (0.45) | BCL2BECN1KDM4D | |
| SCHEMBL3744735 | 0.83 | DPP4 (0.42) | DPP4 | |
| Trifluoroacetic Acid SCHEMBL3742901 | 0.79 | DPP4 (0.51) | DPP4 | |
| SCHEMBL896532 | 0.78 | DPP4 (0.49) | DPP4 | |
| SCHEMBL13078897 | 0.72 | ELOVL6 (0.42) | DPP4 | |
| SCHEMBL3744361 | 0.72 | ELOVL6 (0.42) | DPP4 | |
| SCHEMBL3744329 | 0.71 | DPP4 (0.38) | DPP4 | |
| SCHEMBL13078895 | 0.71 | DPP4 (0.38) | DPP4 | |
| SCHEMBL3749602 | 0.70 | DPP4 (0.53) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338450-B2 | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors | LUPIN LIMITED (IN) | 2012-12-25 | — | — | US | disclosed |
| US-20100291020-A1 | NOVEL COMPOUNDS AS DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS | LUPIN LIMITED (IN) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291020-A1 | NOVEL COMPOUNDS AS DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS | DPP4, DPP7, DPP3 | DPP4 1/4885BCL2 4344/4885BECN1 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.